Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of pharmacological and toxicological methods

• Publication date

  1997-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1056-8719(97)00065-8PMID 9403781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives

  2011cited by this paper
• Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.

  1995cited by this paper
• Section Review: Central & Peripheral Nervous System: Remifentanil and anaesthesia for the future

  1994cited by this paper
• Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models

  1994cited by this paper
• Pharmacokinetic‐pharmacodynamic modeling in drug development: Application to the investigational opioid trefentanil

  1994cited by this paper
• Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

  1993cited by this paper
• Remifentanil: a unique opioid analgesic.

  1993cited by this paper
• Quantification of effect delay and acute tolerance development to morphine in the rat.

  1993cited by this paper
• Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model

  1993cited by this paper
• The Case for Preclinical Pharmacodynamics

  1993cited by this paper
• Cerebral haemodynamic and electrocortical CO2 reactivity in pigs anaesthetized with fentanyl, nitrous oxide and pancuronium

  1993cited by this paper
• Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers

  1992cited by this paper
• Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

  1992cited by this paper
• Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures.

  1992cited by this paper
• Alfentanil‐Induced Hypermetabolism, Seizure, and Histopathology in Rat Brain

  1992cited by this paper
• Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil.

  1991cited by this paper
• Pharmacokinetic‐pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration

  1991cited by this paper
• Pharmacodynamic characterization of the electroencephalographic effects of thiopental in rats

  1991cited by this paper
• Neuromonitoring in hypothermia and in hypothermic hypoxia.

  1991cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.

  1991cited by this paper
• Differential effects of mu‐ and delta‐receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices

  1991cited by this paper
• Pharmacokinetics, pharmacodynamics, and rational opioid selection.

  1991cited by this paper
• Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure: demonstration of a simple animal model for the study of in vivo nitrate tolerance.

  1990cited by this paper
• Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats.

  1990cited by this paper
• Can slow waves in the electrocorticogram (ECoG) help localize epileptic foci?

  1990cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis

  1990cited by this paper
• Determination of the threshold for convulsions by direct cortical stimulation.

  1989cited by this paper
• Focal and/or lateralized polymorphic delta activity. Association with either 'normal' or 'nonfocal' computed tomographic scans.

  1988cited by this paper
• Pharmacodynamic model of tolerance: application to nicotine.

  1988cited by this paper
• Relationships between quantitative EEG measures and pharmacodynamics of alfentanil in dogs.

  1988cited by this paper
• Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure

  1988cited by this paper
• Acute tolerance to cocaine in humans

  1988cited by this paper
• Effects of temperature on the interaction of morphine with opioid receptors.

  1987cited by this paper
• Plasma Concentrations of Alfentanil Required to Supplement Nitrous Oxide Anesthesia for General Surgery

  1986cited by this paper
• Influence of Sufentanil on Cerebral Metabolism and Circulation in the Rat

  1985cited by this paper
• EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

  1985cited by this paper
• Kinetics of cocaine distribution, elimination, and chronotropic effects

  1985cited by this paper
• Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

  1985cited by this paper
• Opioid‐induced epileptogenic phenomena: Anatomical, behavioral, and electroencephalographic features

  1984cited by this paper
• Effects of Sufentanil on Regional Cerebral Glucose Utilization in Rats

  1984cited by this paper
• Local Cerebral Blood Flow with Fentanyl-Induced Seizures

  1984cited by this paper
• Electroencephalographic effects of fentanyl-, sufentanil- and alfentanil anaesthesia in man.

  1984cited by this paper
• Fentanyl‐induced Seizures Activate Subcortical Brain Metabolism

  1984cited by this paper
• Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood.

  1982cited by this paper
• Noncompartmental Analysis Based on Statistical Moment Theory

  1982cited by this paper
• Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action.

  1982cited by this paper
• The Effects of High‐Dose Fentanyl on Cerebral Circulation and Metabolism in Rats

  1982cited by this paper
• Effects of opioid peptides on thermoregulation.

  1981cited by this paper
• Correlation of EEG, computerized tomography, and clinical findings. Study of 100 patients with focal delta activity.

  1981cited by this paper
• Effects of morphine, fentanyl, sufentanil, and the short‐acting morphine‐like analgesic alfentanil on the EEG in dogs

  1981cited by this paper
• Effects of opioid peptides on thermoregulation.

  1981cited by this paper
• Rapid and sensitive gas chromatographic method for the determination of alfentanil and sufentanil in biological samples.

  1981cited by this paper
• Enkephalin blocks inhibitory pathways in the vertebrate CNS

  1980cited by this paper
• Morphine and enkephalin: analgesic and epileptic properties.

  1977cited by this paper
• [Computerized transverse axial tomography in the diagnosis of epilepsy; an electroencephalo-tomographic study (author's transl)].

  1976cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• A safe method for rapidly achieving plasma concentration plateaus

  1974cited by this paper

• Evaluation of different intramuscular injectable anesthetic combinations in rabbits: Impact on anesthetic depth, physiological parameters, and EEG recordings

  2025cites this paper
• The association between body temperature and electrocardiographic parameters in normothermic healthy volunteers

  2020cites this paper
• Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review

  2019cites this paper
• Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models

  2015cites this paper
• Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics.

  2008influential citation
• 3. MODELLING OF BIOPHASE DISTRIBUTION OF MORPHINE IN VIVO

  2007cites this paper
• MODELLING OF THE ELECTROENCEPHALOGRAM EFFECTS OF MORPHINE: INFLUENCE OF BIOPHASE DISTRIBUTION AND P-GLYCOPROTEIN INTERACTION

  2007cites this paper
• IDENTIFICATION OF THE OPERATIONAL MODEL OF AGONISM FOR THE EEG EFFECTS OF OPIOIDS: ESTIMATION OF THE IN VIVO AFFINITY AND INTRINSIC EFFICACY AT THE -OPIOID RECEPTOR

  2007cites this paper
• Influence of biophase distribution and P‐glycoprotein interaction on pharmacokinetic‐pharmacodynamic modelling of the effects of morphine on the EEG

  2007cites this paper
• Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

  2007cites this paper
• Population pharmacokinetic modelling of non‐linear brain distribution of morphine: influence of active saturable influx and P‐glycoprotein mediated efflux

  2007cites this paper
• High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic/pharmacodynamic studies in rats.

  2005cites this paper
• Concurrent ketamine and alfentanil administration: pharmacokinetic considerations.

  2002cites this paper
• Electroencephalography parameters as biomarkers: extrapolation from laboratory animals to humans.

  2002cites this paper
• Relationship between gamma‐hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat

  2001cites this paper
• Pharmacokinetic-Pharmacodynamic Analysis of the EEG Effect of Alfentanil in Rats Followingβ-Funaltrexamine-Induced μOpioid Receptor “Knockdown”In Vivo

  2000cites this paper
• Influence of Hypovolemia on the Pharmacokinetics and the Electroencephalographic Effect of Propofol in the Rat

  2000cites this paper
• Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown" in vivo.

  2000cites this paper
• The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.

  1999cites this paper
• Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat.

  1999cites this paper
• Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.

  1998influential citation
• Influence of Different Fat Emulsion-Based Intravenous Formulations on the Pharmacokinetics and Pharmacodynamics of Propofol

  1998cites this paper
• Pharmacokinetic-pharmacodynamic modelling of the analgesic effect of alfentanil in the rat using tooth pulp evoked potentials.

  1998cites this paper
• Pharmacokinetic‐pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation

  1998cites this paper